How Lundbeck’s CEO aims to keep firm ‘punching above its weight’
Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…